• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Longevity Market
    Longevity News
    Longevity Stocks
    • Longevity Market
    • Longevity News
    • Longevity Stocks
    longevity investing

    Israeli, American Researchers Discover Blood Marker that could Signal Alzheimer’s Diagnosis

    Vivien Diniz
    Feb. 09, 2016 10:29AM PST
    Longevity Investing

    The Jerusalem Post reported that a biological blood marker linked to Alzheimer’s disease could eventually serve as a reliable diagnostic blood test for the progressive, fatal dementia has been identified by researchers at Tel Aviv University, Rambam Medical Center/the Techion-Israel Institute of Technology and Harvard University.

    The Jerusalem Post reported that a biological blood marker linked to Alzheimer’s disease could eventually serve as a reliable diagnostic blood test for the progressive, fatal dementia has been identified by researchers at Tel Aviv University, Rambam Medical Center/the Techion-Israel Institute of Technology and Harvard University.
    According to the article:

    Today, diagnosing Alzheimer’s is a long and complicated process, and most doctors use subjective memory tests of cognitive and functional abilities and behavior changes, she said on Tuesday. In special cases, expensive brain scans are carried out that are not yet available in Israel. Sometimes, invasive tests of the brain and spinal fluids are conducted, noted Gozes of the department of human molecular genetics and biochemistry at TAU’s Sackler Faculty of Medicine and of the Sagol School of Neuroscieces.

    TAU lead researcher Prof. Illana Gozes commented:

    We hope that in the future, it will be possible to use our discovery to develop a simple blood test for this serious disease even in its early stages.

    Click here to view the full article. 

    longevity investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Man holds hand to head as fragments break off representing Alzheimer's disease.

    Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Longevity Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×